283283
Addressing barriers to adoption of iuds among post-abortion clients on the Thailand-burma border
This pilot project aimed to identify and address the service delivery barriers to IUD use and seed a larger initiative to increase access to LARCs along the border.
The study team comprised of international and local researchers conducted 24 key informant interviews with health workers in the reproductive health departments and 24 in-depth interviews with post-abortion (PAC) clients upon discharge from the clinic.
Results indicated a lack of health worker knowledge and experience, and a range of misconceptions and attitudes about IUDs. The majority of PAC clients were not offered an IUD during contraceptive counseling. Data analysis informed the development of a clinic-based intervention to train 20 health workers from the reproductive health departments in IUD counseling, insertion, and removal.
Measurable outcomes include an exponential increase in IUD insertions and a dedicated space for the provision of LARCs at MTC. Future areas of research include expanding border-wide access to IUDs.
Learning Areas:
Public health or related researchLearning Objectives:
Identify counseling, training, and service delivery barriers to IUD utilization among refugee, migrant, and cross border populations utilizing post-abortion care services on the Thailand-Burma border
Explain actionable strategies for improving IUD service delivery on the Thailand-Burma border
Keyword(s): Contraception, Post-Abortion Care
Qualified on the content I am responsible for because: The co-investigators have a combined 15 years of experience exploring reproductive health issues on the Thailand-Burma border. Our work includes interventions and publications related to post-abortion care and family planning that aim to increase access to contraception and improve health service provider training.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.